financetom
Business
financetom
/
Business
/
Evercore hires Goldman banker Kamo for private equity dealmaking, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evercore hires Goldman banker Kamo for private equity dealmaking, sources say
Aug 9, 2024 5:07 AM

NEW YORK, Aug 9 (Reuters) - Investment bank Evercore ( EVR )

has hired a top Goldman Sachs ( GS ) dealmaker as a

senior managing director to help drive its coverage of private

equity firms and alternative asset managers, people familiar

with the matter said on Friday.

David Kamo, who was named global head of dealmaking for

financial sponsors at Goldman last year, will join Evercore ( EVR ) in

the coming months after a period of gardening leave, the sources

said, requesting anonymity as the discussions are confidential.

Evercore ( EVR ) and Goldman both declined to comment.

Over the past year, Evercore ( EVR ) has hired several top

dealmakers from rivals in its push to win more business from

large corporates and private equity firms, amid a slowdown in

dealmaking activity.

Those efforts have started to pay off. Evercore ( EVR ) was ranked

sixth in global league tables for financial advisors during the

first half of 2024, while it was ranked 12 during the same

period last year, according to data compiled by Dealogic.

Kamo joined Goldman in 2016 and became a partner at the bank

in 2020. Before joining Goldman, he spent the previous 10 years

at Lehman Brothers and Barclays, according to his LinkedIn

profile.

Earlier this year, Goldman hired two senior bankers from

JPMorgan, Haidee Lee and Carsten Woehrn, to strengthen its

financial sponsors coverage group.

Deal activity involving private equity firms has rebounded

this year as buyout firms have deployed more capital, after a

spike in financing costs last year triggered a slowdown in

dealmaking. Global leveraged buyout volumes jumped 41% to $286

billion during the first half of 2024, according to Dealogic.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IonQ Stock Is Trading Higher Tuesday: What's Going On?
IonQ Stock Is Trading Higher Tuesday: What's Going On?
Dec 10, 2024
IonQ Inc ( IONQ ) shares are in the spotlight Tuesday amid developments across the quantum computing industry. The company will discuss commercial momentum in the quantum space at a quantum conference on Tuesday. Here’s what you need to know. What To Know: Quantum stocks are in the spotlight Tuesday after Alphabet Inc ( GOOG ) unveiled a new quantum...
C3.Ai, ECS Win US Army Task Order to Modernize Information Collection Management Processes
C3.Ai, ECS Win US Army Task Order to Modernize Information Collection Management Processes
Dec 10, 2024
10:49 AM EST, 12/10/2024 (MT Newswires) -- C3.ai ( AI ) in partnership with ECS have won a task order from the US Army's Program Manager for Intelligence Systems & Analytics to modernize information collection management processes, the company said Tuesday. The partnership will implement C3 AI Decision Advantage, an AI-driven application suite designed for Combined Joint All-Domain Command &...
Rigetti, Quantum Machines Automate Quantum Computer Calibration; Shares Rise
Rigetti, Quantum Machines Automate Quantum Computer Calibration; Shares Rise
Dec 10, 2024
10:45 AM EST, 12/10/2024 (MT Newswires) -- Rigetti Computing ( RGTI ) and Quantum Machines said Tuesday they have successfully automated calibration of a quantum computer using artificial intelligence. Quantum Elements and Qruise automated the calibration process for a 9-qubit quantum computer by combining advanced hardware and software from Rigetti, Quantum Machines, and Nvidia ( NVDA ) , according to...
Compass Therapeutics Names Barry Shin CFO
Compass Therapeutics Names Barry Shin CFO
Dec 10, 2024
10:48 AM EST, 12/10/2024 (MT Newswires) -- Compass Therapeutics ( CMPX ) said Tuesday it appointed Barry Shin as chief financial officer, effective Dec. 9. Shin previously worked as executive vice president, chief operating officer and chief financial officer at Trevena ( TRVN ) , the company said. Compass Therapeutics' ( CMPX ) shares were up 5.5% in recent trading....
Copyright 2023-2025 - www.financetom.com All Rights Reserved